1254962-95-2

Basic information

• Product Name: 6-[(3-butyl-5-methyl-isoxazol-4-ylmethyl)-amino]-nicotinic acid methyl ester
• CAS NO: 1254962-95-2
• Molecular Weight: 303.361
• Mol File: 1254962-95-2.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: 6-[(3-butyl-5-methyl-isoxazol-4-ylmethyl)-amino]-nicotinic acid methyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: 6-[(3-butyl-5-methyl-isoxazol-4-ylmethyl)-amino]-nicotinic acid methyl ester(1254962-95-2)
• EPA Substance Registry System: 6-[(3-butyl-5-methyl-isoxazol-4-ylmethyl)-amino]-nicotinic acid methyl ester(1254962-95-2)

Safety Data

• Hazardous Substances Data: 1254962-95-2(Hazardous Substances Data)

Upstream product

• 1254962-93-0 2-(3-butyl-5-methyl-isoxazol-4-ylmethyl)-isoindole-1,3-dione 
• 1254962-92-9 3-butyl-4-chloromethyl-5-methyl-isoxazole 
• 1239465-20-3 3-butyl-5-methyl-isoxazole-4-carboxylic acid ethyl ester 
• 1239465-21-4 (3-butyl-5-methyl-isoxazol-4-yl)-methanol 
• 5775-76-8 valeraldoxime 
• 73781-91-6 6-Chloronicotinic acid methyl ester 
• 1254962-94-1 C-(3-butyl-5-methyl-isoxazol-4-yl)-methylamine 

Relevant articles and documents

ISOXAZOLE-PYRIDINE DERIVATIVES AS GABA MODULATORS

The present invention is concerned with novel isoxazole derivatives of formula (I) wherein X, R1, R2, R3 and R4 are as described herein, as well as pharmaceutically acceptable salts and esters thereof. The active compounds of the present invention have affinity and selectivity for GABA A α5 receptor. Further the present invention is concerned with the manufacture of the active compounds of formula (I), pharmaceutical compositions containing them and their use as medicaments.